Logo-bi
Review
Mohammad Reza Asgharzadeh, Jaleh Barar ORCID, Mohammad M. Pourseif, Morteza Eskandani, Mojtaba Jafari Niya, Mohammad Reza Mashayekhi, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(2): 115-133. doi: 10.15171/bi.2017.15
PMCID: PMC5524986     PMID: 28752076     Scopus ID: 85027460324    
Original Research
Mohammad Reza Asgharzadeh, Mohammad M. Pourseif, Jaleh Barar ORCID, Morteza Eskandani, Mojtaba Jafari Niya, Mohammad Reza Mashayekhi, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(3): 145-159. doi: 10.15171/bi.2019.19
PMCID: PMC6726749     PMID: 31508330     Scopus ID: 85071154393    
Increased expression of TSGA10 associated with the reduced metastasis in the MDA-MB-231 cells. TSGA10 showed interaction with HIF-1α with high affinity. TSGA10 expression is altered under the hypoxia, indicating its potential as a bio-target for cancer therapy.
Editorial
Mitra Dolatkhah, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(4): 195-197. doi: 10.15171/bi.2019.24
PMCID: PMC6879713     PMID: 31799155     Scopus ID: 85077126191    
Dr. Yadollah Omidi (Pharm.D., Ph.D.) is a Professor of Pharmaceutical Sciences at TUOMS Faculty of Pharmacy, working on advanced multifunctional nanobiosystems. He has worked at Cardiff University and University of Pennsylvania. He has published over 210 papers and 18 book chapters, supervised and mentored over 100 graduate/postgraduate students/researchers.
Original Research
Fatemeh Abedi Jafari ORCID, Asghar Abdoli* ORCID, Reza Pilehchian, Neda Soleimani, Seyed Masoud Hosseini
BioImpacts. 2022;12(5): 405-414. doi: 10.34172/bi.2021.25
PMCID: PMC9596882     PMID: 36381634     Scopus ID: 85140264436    
The experiment concluded that the C. novyi nontoxic might be a suitable and safe candidate, a novel therapeutic approach to encounter such hypoxic regions in the center of tumors
Letter to the Editor
Aleksandr L. Urakov* ORCID, Natalya A. Urakova, Ilnur I. Yagudin, Milena D. Svetova, Darya O. Suntsova
BioImpacts. 2022;12(4): 393-394. doi: 10.34172/bi.2022.23877
PMCID: PMC9376158     PMID: 35975207     Scopus ID: 85138077187    
The purpose of this letter was to present a model for evaluating the biological activity of drugs, which can become a new vector for the development of effective ways to increase blood oxygenation across pulmonary and save the lives of patients with severe atypical pneumonia complicated by respiratory obstruction in COVID-19.
Letter to the Editor
Aleksandr L. Urakov* ORCID, Natalya A. Urakova
BioImpacts. 2022;12(5): 477-478. doi: 10.34172/bi.2022.23995
PMCID: PMC9596884     PMID: 36381636     Scopus ID: 85140223132    
Aleksandr Urakov is a professor, head of the department of General and Clinical Pharmacology at the Izhevsk State Medical Academy (ISMA). His specific research interest is in physical-chemical materials science, pharmacy, and medicine to develop new inventions designed to diagnose, prevent, and treat life-threatening conditions.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge